The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients

Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin

(2016) Vincenzo Formica et al.   Cancer Biomarkers

First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors

(2016) Caterina Vivaldi et al.   INTERNATIONAL JOURNAL OF CANCER

Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma

(2016) Lianyuan Tao et al.   MEDICINE

Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma

(2016) Fei Ji et al.   MEDICINE

Role of immune cells in pancreatic cancer from bench to clinical application

(2016) Jae Hyuck Chang et al.   MEDICINE

Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer

(2016) Suguru Yamada et al.   MEDICINE

The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer

(2016) Mengwan Wu et al.   TUMOR BIOLOGY

Stromal biology and therapy in pancreatic cancer: a changing paradigm

(2015) Albrecht Neesse et al.   GUT

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

(2015) D. Goldstein et al.   JNCI-Journal of the National Cancer Institute

Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer

(2015) Q. Qi et al.   PANCREATOLOGY

Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: A meta-analysis

(2015) Jian-Jun Yang   WORLD JOURNAL OF GASTROENTEROLOGY

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib

(2015) Luca Faloppi et al.   Oncotarget

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

(2015) D. Goldstein et al.   JNCI-Journal of the National Cancer Institute

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

(2014) L. Rahib et al.   CANCER RESEARCH

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

(2014) Arnoud J. Templeton et al.   JNCI-Journal of the National Cancer Institute

Complex role for the immune system in initiation and progression of pancreatic cancer

(2014) Kristin S Inman   WORLD JOURNAL OF GASTROENTEROLOGY

Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients

(2013) J Szkandera et al.   BRITISH JOURNAL OF CANCER

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

(2013) M Stotz et al.   BRITISH JOURNAL OF CANCER

External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients

(2013) Joanna Szkandera et al.   PLoS One

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer

(2012) Jordan M. Winter et al.   JOURNAL OF SURGICAL ONCOLOGY

Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer

(2012) De-shen Wang et al.   MEDICAL ONCOLOGY

Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio

(2010) Imran Bhatti et al.   AMERICAN JOURNAL OF SURGERY